212 related articles for article (PubMed ID: 30154949)
1. 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1
Abdel-Naim AB; Neamatallah T; Eid BG; Esmat A; Alamoudi AJ; Abd El-Aziz GS; Ashour OM
Oxid Med Cell Longev; 2018; 2018():4389484. PubMed ID: 30154949
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
3. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
4. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
5. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
6. The potential protective effects of estradiol and 2-methoxyestradiol in ischemia reperfusion-induced kidney injury in ovariectomized female rats.
Hassan E; Allam S; Mansour AM; Shaheen A; Salama SA
Life Sci; 2022 May; 296():120441. PubMed ID: 35240160
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.
Atawia RT; Mosli HH; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1131-40. PubMed ID: 25164963
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of Thymoquinone on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.
Al-Trad B; Al-Zoubi M; Qar J; Al-Batayneh K; Hussien E; Muhaidat R; Aljabali A; Alkhateeb H; Al Omari G
Phytother Res; 2017 Dec; 31(12):1910-1915. PubMed ID: 28960541
[TBL] [Abstract][Full Text] [Related]
10. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
11. Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats.
Shoieb SM; Esmat A; Khalifa AE; Abdel-Naim AB
Food Chem Toxicol; 2018 Jan; 111():650-659. PubMed ID: 29247772
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol inhibits carotid artery intimal hyperplasia induced by balloon injury via inhibiting JAK/STAT axis in rats.
Azhar AS; Abdel-Naim AB; Ashour OM
Environ Sci Pollut Res Int; 2022 Aug; 29(39):59524-59533. PubMed ID: 35384535
[TBL] [Abstract][Full Text] [Related]
13. Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.
Mosli HH; Esmat A; Atawia RT; Shoieb SM; Mosli HA; Abdel-Naim AB
Sci Rep; 2015 Oct; 5():15639. PubMed ID: 26492952
[TBL] [Abstract][Full Text] [Related]
14. Molecular modelling predicts that 2-methoxyestradiol disrupts HIF function by binding to the PAS-B domain.
Poch A; Villanelo F; Henriquez S; Kohen P; Muñoz A; Strauss JF; Devoto L
Steroids; 2019 Apr; 144():21-29. PubMed ID: 30738071
[TBL] [Abstract][Full Text] [Related]
15. 6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis.
Binmahfouz LS; Almukadi H; Alamoudi AJ; El-Halawany AM; Abdallah HM; Algandaby MM; Mohamed GA; Ibrahim SRM; Alghamdi FA; Al-Shaeri M; Abdel-Naim AB
Plants (Basel); 2022 Oct; 11(19):. PubMed ID: 36235468
[TBL] [Abstract][Full Text] [Related]
16. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
17. Piceatannol Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Modulation of Nrf2/HO-1/NFκB Axis.
Eid BG; Abdel-Naim AB
Front Pharmacol; 2020; 11():614897. PubMed ID: 33519479
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
[TBL] [Abstract][Full Text] [Related]
19. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
20. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
